1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow dactolisib: new trials by email Literature Review of dactolisib trials Research Report on dactolisib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475 MK - 3475, Suppressor of the PI3K/Akt pathways - Glioblastoma | Phase 1 / Phase 2 | Unknown | Medical Research Council | 58 | 2013-03-01 | 2016-02-24 |
Glioblastoma (1) · Gliosarcoma (1)
Belgium (1) · Germany (1) · Italy (1) · Poland (1) · Russia (1) · Spain (1) · Switzerland (1) · Ukraine (1) · United Kingdom (1) · United States (1)
Jann Lee, PhD (1)